Mird237 -

No. While both are used in tissue healing, they act on completely different receptors. MIRD237 targets FGFRs; TB-500 targets actin.

In the realm of applied research, is closely associated with the National Applied Research Seminar (SENTRINOV) , a prominent academic forum organized by the Indonesian Association of Science (ISAS). mird237